GENESYS — Genesys International Balance Sheet
0.000.00%
- IN₹24.10bn
- IN₹23.09bn
- IN₹3.11bn
- 37
- 17
- 48
- 22
Annual balance sheet for Genesys International, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 110 | 274 | 637 | 302 | 39.4 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 628 | 983 | 1,699 | 2,504 | 4,283 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 753 | 1,280 | 2,434 | 3,313 | 4,551 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 274 | 325 | 659 | 757 | 691 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,041 | 3,190 | 5,056 | 6,346 | 7,780 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 367 | 731 | 691 | 1,089 | 1,892 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,308 | 1,142 | 1,002 | 1,454 | 2,224 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 1,733 | 2,048 | 4,054 | 4,892 | 5,555 |
| Total Liabilities & Shareholders' Equity | 3,041 | 3,190 | 5,056 | 6,346 | 7,780 |
| Total Common Shares Outstanding |